solo private practice
Infectious Disease
Dr. Franco A. Felizarta, MD
|
|
Give Review
Franco A. Felizarta is an expert in the field of Infectious Disease. He graduated from University of the Philippines College of Medicine. Dr. Franco A. Felizarta is also a published doctor. He has 11 publication published. The most recent publication is: Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results from the SINGLE Rando... He accepts Medicare.
Publications
- Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results from the SINGLE Rando...
- Ombitasvir/Paritaprevir/r and Dasabuvir Plus Ribavirin in HCV Genotype 1-Infected Patients on Methadone or Buprenorphine.
- Pharmacokinetics of Etravirine Combined with Atazanavir/Ritonavir and a Nucleoside Reverse Transcriptase Inhibitor in Antiretroviral Treatment-Experienced, HIV-1-Infec...
- Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferi...
- Overall safety profile of boceprevir plus peginterferon alfa-2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 cli...
- Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study.
- Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-nai...
- Pharmacokinetics of fosamprenavir plus ritonavir in human immunodeficiency virus type 1-infected adult subjects with hepatic impairment.
- Pharmacokinetic assessment of nevirapine and metabolites in human immunodeficiency virus type 1-infected patients with hepatic fibrosis.
- Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial.
Schools
University Of The Philippines Manila College Of Medicine
SUNY Health Science Center
Procedures Preformed
- Blood Culture for Bacteria
- Blood Draw
- Blood Test
- Lab Service
- View All
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
SUNY Health Science Center at Brooklyn -
University of the Philippines College of Medicine
Hospital
-
Bakersfield Memorial Hospital -
Mercy Hospitals of Bakersfield
Drug Facts
| NPI NUMBER | 1629004957 | |
| NPPES Provider LastName | FELIZARTA | |
| NPPES Provider FirstName | FRANCO | |
| NPPES Provider ZIPCode | 93389 | |
| NPPES Provider State | CA | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 10316.0 | |
| Distinct Opioid Count | 6.0 | |
| Opioid Claim Count | 731.0 | |
| Percent Opioid Claims | 7.09 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1629004957 |
| Last Name Of The Provider | FELIZARTA |
| First Name Of The Provider | FRANCO |
| View All |
Similar Doctors
|
Dr. Rasha Kuran, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Arash Heidari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shaker Itani, MD |
|
|
Dr. Mui S. Byron, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Randolph D. Senining, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Shankar Raman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shehla Baqi, MD |
|
|
Dr. Anthony Milanes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kimberlee S. Fong, DO |